Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection.
Saved in:
| Title: | Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection. |
|---|---|
| Authors: | Gao D; Department of Pharmacy, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing Engineering Research Center for Nervous System Drugs, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China.; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Niu M; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Wei SZ; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Zhang CE; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Zhou YF; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Yang ZW; Department of Pharmacy, the Sixth Medical Center, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Li L; Department of Pharmacy, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing Engineering Research Center for Nervous System Drugs, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China., Wang JB; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China., Zhang HZ; College of Pharmacy and Chemistry, Dali University, Dali, China., Zhang L; Department of Pharmacy, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing Engineering Research Center for Nervous System Drugs, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China., Xiao XH; Department of China Military Institute of Chinese Materia, the Fifth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2020 May 25; Vol. 11, pp. 746. Date of Electronic Publication: 2020 May 25 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2020.00746 |
